Development of simultaneous quantitative analytical method for metabolites of hexosamine biosynthesis pathway in lung cancer cells using ultra‐high‐performance liquid chromatography‐tandem mass spectrometry
Biomedical Chromatography · 2023
DOI: 10.1002/bmc.5642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2023. Verfasst von Yerim Seo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Hexosamines, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Korea Institute of Science and Technology Institutional Program.
Abstract (Originalsprache)
The hexosamine biosynthesis pathway (HBP) is a glucose metabolism pathway that produces uridine diphosphate N ‐acetyl glucosamine (UDP‐GlcNAc). Substantial changes in HBP, including elevated HBP flux and UDP‐GlcNAc levels, are associated with cancer pathogenesis. Particularly, cancer cells expressing oncogenic Kirsten rat sarcoma virus (KRAS) are highly dependent on HBP for growth and survival. To differentiate between HBP metabolites in KRAS wild‐type (WT) and mutant (MT) lung cancer cells, a simultaneous quantitative method for analyzing seven HPB metabolites was developed using ultra‐high‐performance liquid chromatography‐tandem mass spectrometry. A simple method without complicated preparation steps, such as derivatization or isotope labeling, was optimized for the simultaneous analysis of highly hydrophilic HBP metabolites, and the developed method was successfully verified. The intra‐ and inter‐day coefficients of variation were less than 15% for all HBP metabolites, and the recovery was 89.67–114.5%. All results of the validation list were in accordance with ICM M10 guidelines. Through this method, HBP metabolites in lung cancer cells were accurately quantified, and it was confirmed that all HBP metabolites were upregulated in KRAS MT cells compared with KRAS WT lung cancer cells. We expect that this will be a useful tool for metabolic research on cancer and for the development of new drugs for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology, Seoul, Republic of Korea.
- Department of Fundamental Pharmaceutical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
- Division of Bio-Medical Science and Technology, Kist School, Korea University of Science and Technology (UST), Seoul, Republic of Korea.
ORCID-Profile: Eun Kyoung Chung, Byung Hwa Jung
Förderung
- Korea Institute of Science and Technology Institutional Program
Zitieren
APA
Seo, Y., Chung, E. K., & Jung, B. H. (2023). Development of simultaneous quantitative analytical method for metabolites of hexosamine biosynthesis pathway in lung cancer cells using ultra‐high‐performance liquid chromatography‐tandem mass spectrometry. Biomedical Chromatography. https://doi.org/10.1002/bmc.5642
Vancouver
Seo Y, Chung EK, Jung BH. Development of simultaneous quantitative analytical method for metabolites of hexosamine biosynthesis pathway in lung cancer cells using ultra‐high‐performance liquid chromatography‐tandem mass spectrometry. Biomedical Chromatography. 2023. doi:10.1002/bmc.5642
BibTeX
@article{Seo2023,
author = {Seo, Yerim and Chung, Eun Kyoung and Jung, Byung Hwa},
title = {Development of simultaneous quantitative analytical method for metabolites of hexosamine biosynthesis pathway in lung cancer cells using ultra‐high‐performance liquid chromatography‐tandem mass spectrometry},
journal = {Biomedical Chromatography},
year = {2023},
doi = {10.1002/bmc.5642}
}
EUVIMED